Business Context and Reporting Period
Company: DaVita Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 8, 2005
Reporting Period: Quarter and fiscal year ended December 31, 2004.
This filing serves to announce the issuance of a press release containing financial results for the specified period. The actual numerical financial data is contained in Exhibit 99.1 (the press release) and is not detailed within the body of this Form 8-K text.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. It references the existence of these metrics in the attached press release but does not list them.
The company utilizes several non-GAAP financial measures to supplement GAAP results, including:
- Net income excluding Medicare lab recoveries.
- Free cash flow.
- Operating cash flows and free cash flows excluding Medicare lab recoveries related to prior period services and tax benefits from stock option exercises.
- Operating income excluding Medicare lab recoveries, depreciation, amortization, and minority interest (used for debt leverage ratio calculations).
- Revenue excluding Medicare lab recoveries.
Material Changes
The filing text does not provide specific data to quantify material changes versus prior comparable periods. It notes that the company historically reports non-GAAP measures to exclude non-recurring expenses and Medicare lab recoveries for prior period services, which can cause unusual fluctuations in operating performance.
Guidance, Outlook, and Risks
Outlook: The attached press release contains forward-looking statements regarding performance for 2005.
Risks and Uncertainties: The company states that forward-looking statements involve substantial known and unknown risks and uncertainties that could cause actual results to differ materially from expectations. These risks are detailed in the company's most recent Annual Report on Form 10-K (fiscal year ended December 31, 2003) and Quarterly Reports on Form 10-Q (fiscal quarter ending September 30, 2004).
Unusual Items: The filing highlights the exclusion of Medicare lab recoveries for prior period services as a factor that results in unusual fluctuations in operating performance.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific GAAP and non-GAAP financial figures for the quarter and year ended December 31, 2004.
- Examine the reconciliation tables in the press release to understand the adjustments made to derive non-GAAP measures.
- Consult the Form 10-K for the fiscal year ended December 31, 2003, and the Form 10-Q for the quarter ended September 30, 2004, for detailed risk factors and historical context.
- Verify the impact of Medicare lab recoveries on reported revenue and operating income.